<i>Candida parapsilosis</i> and echinocandins: should the clinical laboratory drop anidulafungin Etest from the susceptibility testing panel? [PDF]
Vahedi-Shahandashti R +2 more
europepmc +1 more source
Antifungal and anti-virulence activities of cinnamon, thyme, and clove essential oils against <i>Candida</i> species. [PDF]
Ahaik I +5 more
europepmc +1 more source
The in vitro activity of iron chelator deferiprone against Candida (Candidozyma) auris in combination with antifungal agents. [PDF]
Tóth Z +7 more
europepmc +1 more source
Central line-associated <i>Cyberlindnera fabianii</i> fungemia: A case report and review of diagnostic and therapeutic challenges. [PDF]
Sasi S +4 more
europepmc +1 more source
Prevalence and molecular basis of resistance to echinocandins among clinical Candida glabrata isolates in Guangdong province, China. [PDF]
Lin W +5 more
europepmc +1 more source
The Upcoming Antifungal Drugs in Clinical Development for the Treatment of Invasive Candidiasis. [PDF]
Zubovskaia A, Vazquez JA.
europepmc +1 more source
Global surveillance of <i>Candida albicans</i>: MIC distributions, resistance patterns, and temporal trends from the Antimicrobial Testing Leadership and Surveillance program (2015-2024). [PDF]
Cai G, Zhang Z.
europepmc +1 more source
Hospital Indoor Air as a Reservoir of Opportunistic Filamentous Fungi: Species Diversity and Antifungal Susceptibility. [PDF]
Pimentel J +9 more
europepmc +1 more source
Evaluating the Efficacy and Safety of Anidulafungin and Caspofungin in Invasive Candida Infections in Intensive Care Units in India: A Prospective, Observational, Multicenter, Open-Label Study. [PDF]
Mehta Y, Rao PV, Mahajan R, Panackel C.
europepmc +1 more source
First case of a human <i>Candida berthetii</i> systemic infection in a preterm infant: a case report. [PDF]
Francisco EC +9 more
europepmc +1 more source

